ENEA-IRIS Open Archive è l’archivio della produzione scientifica dell'ENEA, realizzato con l'obiettivo di raccogliere, catalogare e rendere facilmente accessibili in rete i risultati della ricerca. Gli autori dell’ENEA provvedono a depositare le proprie pubblicazioni (articoli su rivista, presentazioni a congressi, report, ecc.). In particolare, quelle finanziate dalla Commissione Europea nell’ambito del programma H2020 (che prevede il deposito obbligatorio in un Repository), una volta caricate, vengono automaticamente importate dal portale europeo OpenAIRE. È possibile inserire, o importare direttamente dalle banche dati previste, le informazioni descrittive del documento e anche allegare, ove consentito dalla normativa sul diritto d'autore, il testo completo della pubblicazione.

ENEA-IRIS Open Archive utilizza la piattaforma IRIS (Institutional Research Information System) sviluppata da CINECA.

Non-alcoholic fatty liver disease (NAFLD) affects 3-12% of the general pediatric population. HMGB1 protein is presently considered a potent inflammatory mediator in several liver diseases, even if its role in NAFLD is still unknown in clinical studies. Here we investigated the relationships between circulating HMGB1, TGF-β and MCP-1 and liver damage in pediatric NAFLD. HMGB1, TGF-β and MCP-1 plasma levels were measured in 110 obese children with biopsy-proven NAFLD and 40 age-matched obese controls. HMGB1, TGF-β and MCP-1, ALT, AST and cholesterol plasma levels were significantly higher in NAFLD than in control children. A significant association between increased levels of HMGB1, TGF-β and MCP-1 and high degrees of fibrosis was found. In this study, we showed for the first time that circulating levels of HMGB1 were raised in children with NAFLD and strongly correlated with fibrosis and systemic inflammation. © 2014 Informa UK, Ltd.

Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease

Stronati, L.;Vitali, R.
2014-01-01

Abstract

Non-alcoholic fatty liver disease (NAFLD) affects 3-12% of the general pediatric population. HMGB1 protein is presently considered a potent inflammatory mediator in several liver diseases, even if its role in NAFLD is still unknown in clinical studies. Here we investigated the relationships between circulating HMGB1, TGF-β and MCP-1 and liver damage in pediatric NAFLD. HMGB1, TGF-β and MCP-1 plasma levels were measured in 110 obese children with biopsy-proven NAFLD and 40 age-matched obese controls. HMGB1, TGF-β and MCP-1, ALT, AST and cholesterol plasma levels were significantly higher in NAFLD than in control children. A significant association between increased levels of HMGB1, TGF-β and MCP-1 and high degrees of fibrosis was found. In this study, we showed for the first time that circulating levels of HMGB1 were raised in children with NAFLD and strongly correlated with fibrosis and systemic inflammation. © 2014 Informa UK, Ltd.
2014
Monocyte chemoattractant protein-1;Non-alcoholic fatty liver disease;Liver fibrosis;High mobility group box 1;TGF β
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12079/2090
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
social impact